V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212575 | 20079184 | 1.81 | 79 | Palliative (P) | 2016-06-09 | 2016-06-10 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100778776 |
| 20212577 | 20079185 | 1.69 | 96.05 | Neo-adjuvant (N) | 2017-12-14 | 2017-12-30 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100987682 |
| 20212578 | 20079186 | 1.67 | 44.1 | null | 2017-12-13 | 2017-12-15 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101184925 |
| 20212579 | 20079187 | 1.56 | 71.8 | Palliative (P) | 2017-11-12 | 2017-11-26 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100201184 |
| 20212580 | 20079188 | 1.6 | 83.4 | Palliative (P) | 2019-01-12 | 2019-01-16 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 101602604 |
| 20212581 | 20079189 | null | null | Neo-adjuvant (N) | 2022-02-14 | 2022-03-14 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101684841 |
| 20212582 | 20079190 | 1.7 | 81 | Curative (C) | 2020-08-13 | 2020-08-28 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100778042 |
| 20212583 | 20079191 | 1.83 | 90.4 | Palliative (P) | 2017-10-21 | 2017-10-29 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101397757 |
| 20212584 | 20079192 | 1.85 | 98.4 | Adjuvant (A) | 2019-04-19 | 2019-05-08 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101342937 |
| 20212586 | 20079193 | 1.67 | 59 | Palliative (P) | null | 2017-06-25 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101328520 |
| 20212587 | 20079194 | 1.62 | 83.7 | Palliative (P) | 2016-11-18 | 2016-11-21 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100475658 |
| 20212588 | 20079195 | 1.66 | 88.2 | Neo-adjuvant (N) | 2018-07-24 | 2018-07-24 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101558732 |
| 20212589 | 20079196 | 1.62 | 125 | null | null | 2017-02-02 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101125818 |
| 20212590 | 20079197 | 0 | 0 | null | 2019-04-06 | 2019-07-09 | Doxorubicin chemoembolisation | N | null | DOXORUBICIN EMBOLISATION | 101368052 |
| 20212591 | 20079198 | 0 | 0 | Palliative (P) | 2017-05-21 | 2017-05-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101849529 |
| 20212593 | 20079199 | 1.65 | 63.9 | Palliative (P) | 2018-05-09 | 2018-05-22 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100140811 |
| 20212595 | 20079200 | 1.64 | 86.4 | Palliative (P) | 2018-08-19 | 2018-08-31 | CAPECITABINE + CARBOPLATIN | N | Y | CAPECITABINE + CARBOPLATIN | 100118903 |
| 20212596 | 20079201 | 1.84 | 66.6 | Curative (C) | 2019-12-25 | 2020-01-02 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101699071 |
| 20212597 | 20079202 | null | 52 | Palliative (P) | 2017-11-09 | 2017-12-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100685744 |
| 20212599 | 20079203 | 1.57 | 76.5 | Palliative (P) | 2019-08-26 | 2019-08-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101214983 |
| 20212600 | 20079204 | 1.64 | 72.4 | Curative (C) | 2017-09-26 | 2017-09-28 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101400987 |
| 20212602 | 20079206 | 1.76 | 59 | Palliative (P) | 2017-06-01 | 2017-06-08 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100078046 |
| 20212603 | 20079207 | 0 | 71.5 | Adjuvant (A) | 2017-10-14 | 2017-10-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101029610 |
| 20212605 | 20079208 | null | 91 | Neo-adjuvant (N) | 2019-04-06 | 2019-05-08 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100488539 |
| 20212606 | 20079209 | 1.71 | 54.4 | Palliative (P) | 2019-05-31 | 2019-06-24 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100285123 |
| 20212608 | 20079210 | 1.72 | 83 | Palliative (P) | 2019-03-14 | 2019-03-25 | CAPECITABINE + CARBOPLATIN | 2 | N | DOXORUBICIN EMBOLISATION | 100879495 |
| 20212609 | 20079211 | 0 | 0 | Curative (C) | 2016-07-24 | 2016-08-20 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100003257 |
| 20212610 | 20079212 | 1.6 | 70.3 | Curative (C) | 2016-10-09 | 2016-10-09 | CAPECITABINE + CARBOPLATIN | N | Y | CAPECITABINE + CARBOPLATIN | 101534457 |
| 20212613 | 20079213 | 0 | 0 | Palliative (P) | null | 2019-01-20 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101057557 |
| 20212614 | 20079214 | 1.81 | 73 | Palliative (P) | 2019-04-17 | 2019-04-17 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100042409 |
| 20212616 | 20079215 | null | 82.6 | Neo-adjuvant (N) | 2017-06-07 | 2017-06-24 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101123623 |
| 20212617 | 20079216 | 1.68 | 80.5 | null | 2019-04-25 | 2019-06-10 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100295719 |
| 20212618 | 20079217 | 1.77 | 124.1 | Palliative (P) | 2017-12-27 | 2018-01-11 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100341634 |
| 20212619 | 20079218 | 1.64 | 107 | Palliative (P) | 2016-10-23 | 2016-10-26 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101517771 |
| 20212620 | 20079219 | 1.6 | 59.1 | Palliative (P) | null | 2017-09-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101331358 |
| 20212621 | 20079220 | 1.72 | 66.7 | Curative (C) | 2019-05-16 | 2019-05-16 | Capecitabine (21days) + Carboplatin | 2 | N | TRIAL UNSPECIFIED | 101805446 |
| 20212622 | 20079221 | 1.55 | 74 | null | 2018-03-11 | 2018-03-11 | Capecitabine (21days) + Carboplatin | 02 | null | CISPLATIN + FLUOROURACIL | 100842014 |
| 20212623 | 20079222 | 1.68 | 83.9 | Palliative (P) | 2017-08-15 | 2017-08-21 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101180046 |
| 20212624 | 20079223 | 1.84 | 86.3 | Neo-adjuvant (N) | 2017-07-17 | 2017-07-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100071942 |
| 20212625 | 20079224 | 0 | 0 | Palliative (P) | 2017-08-07 | 2017-09-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101317839 |
| 20212626 | 20079225 | 1.7 | 77 | Curative (C) | 2017-08-06 | 2017-08-07 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 100680010 |
| 20212628 | 20079226 | 0 | 0 | Neo-adjuvant (N) | 2019-04-14 | 2019-04-16 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100128853 |
| 20212629 | 20079227 | 1.67 | 61.9 | Palliative (P) | 2018-12-03 | 2018-12-08 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 100798152 |
| 20212630 | 20079228 | 1.63 | 108.1 | Palliative (P) | 2020-02-19 | 2020-03-05 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 101711050 |
| 20212631 | 20079229 | 1.66 | 67.8 | Curative (C) | 2019-06-29 | 2019-06-29 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 101064080 |
| 20212632 | 20079230 | 1.72 | 60.8 | Palliative (P) | 2019-03-29 | 2019-03-29 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101621011 |
| 20212633 | 20079231 | 1.66 | 103 | Neo-adjuvant (N) | 2017-10-20 | 2017-10-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101366201 |
| 20212634 | 20079232 | 1.67 | 62 | Palliative (P) | 2018-05-24 | 2018-05-25 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 100955653 |
| 20212635 | 20079233 | 1.63 | 59 | Neo-adjuvant (N) | 2019-05-11 | 2019-05-26 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101467907 |
| 20212636 | 20079234 | 1.68 | 76.1 | Palliative (P) | 2018-11-03 | 2018-11-23 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101095261 |